Clinical significance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 2, 2009, Pages 241-245

  Delektorskaya, V V ^a   Chemeris, G Yu ^a   Kononets, P V ^a   Grigorchuk, A Yu ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

EGFR; Esophageal cancer; HER 2; Immunohistochemistry; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 74949144284     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0659-z     Document Type: Article

References (15)

1. M. Akamatsu, T. Matsumoto, K. Oka, et al., Int. J. Radiat. Oncol. Biol. Phys., 57, No. 5, 1323-1327 (2003).
2. M. Dreilich, A. Wanders, D. Brattstrom, et al., Dis. Esophagus, 19, No. 4, 224-231 (2006).
3. L. Gibault, J. P. Metges, V. Conan-Charlet, et al., Br. J. Cancer, 93, No. 1, 107-115 (2005).
4. I. Gockel, M. Moehler, K. Frerichs, et al., Oncol. Rep., 20, No. 4, 845-850 (2008).
5. M. Gotoh, H. Takiuchi, S. Kawabe, et al., Jpn. J. Clin. Oncol., 37, No. 9, 652-657 (2007).
6. M. Hanawa, S. Suzuki, Y. Dobashi, et al., Int. J. Cancer, 118, No. 5, 1173-1180 (2006).
7. D. M. Lehrbach, M. E. Nita, and I. Cecconello, Arq. Gastroenterol., 40, No. 4, 256-261 (2003).
8. D. C. Lin, X. L. Du, and M. R. Wang, Dis. Esophagus, 22, No. 1, 9-20 (2009).
9. K. Mimura, K. Kono, M. Hanawa, et al., Br. J. Cancer, 92, No. 7, 1253-1260 (2005).
10. S. Morgan and J. R. Grandis, Exp. Cell Res., 315, No. 4, 572-582 (2009).
11. U. Reichelt, P. Duesedau, M. Tsourlakis, et al., Modern Pathol., 20, No. 1, 120-129 (2007).
12. I. Rubin and Y. Yarden, Ann. Oncol., 12, Suppl. 1, S3-S8 (2001).
13. Y. Sato-Kuwabara, J. I. Neves, J. H. Fregnani, et al., BMC Cancer, 9, 6 (2009).
14. P. Sunpaweravong, S. Sunpaweravong, P. Puttawibul, et al., J. Cancer Res. Clin. Oncol., 131, No. 2, 111-119 (2005).
15. Y. Yarden and M. X. Sliwkowski, Nat. Rev. Mol. Cell Biol., 2, No. 2, 127-137 (2001).